Trichomegaly of the Eyelashes During Therapy With Epidermal Growth Factor Receptor Inhibitors
| Autor: | Gabriella Fabbrocini, Dario Bianca, Sara Cacciapuoti, Luigia Panariello, Fabio Ayala |
|---|---|
| Přispěvatelé: | Fabbrocini, Gabriella, Panariello, Luigia, Cacciapuoti, Sara, Bianca, D, Ayala, Fabio |
| Rok vydání: | 2012 |
| Předmět: |
medicine.medical_specialty
Epidermal Growth Factor Receptor Inhibitors Antineoplastic Agents Dermatology skin toxicitie Erlotinib Hydrochloride EGFR inhibitor therapy medicine Mucositis Humans Immunology and Allergy Trichomegaly Epidermal growth factor receptor Adverse effect Papulopustular rash EGFR inhibitors Eyelashes integumentary system biology business.industry Panitumumab Antibodies Monoclonal Exanthema Middle Aged medicine.disease ErbB Receptors Paronychia Quinazolines biology.protein Female Drug Eruptions medicine.symptom Hair Diseases business |
| Zdroj: | Dermatitis. 23:237-238 |
| ISSN: | 1710-3568 |
| DOI: | 10.1097/der.0b013e31826e45d7 |
| Popis: | A wide spectrum of skin toxicities has been described in patients receiving epidermal growth factor receptor (EGFR), inhibitors, including papulopustular rash, xerosis and fissures, pruritus, mucositis, paronychia, and hair changes.Trichomegaly of the eyelashes is a rare adverse effect of EGFR inhibitor therapy and is characterized by a paradoxical overgrowth of eyelashes. We present 3 cases of trichomegaly occurred during EGFR inhibitor therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|